Neurooncology;Neuroonkologie

Nervenarzt

Volumn 74, Issue 12, 2003, Pages 1139-1149

  Weller, M ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Brain tumor; Chemotherapy; Neurooncology; Neurosurgery; Radiotherapy

Indexed keywords

AGE; ASTROCYTOMA; BRAIN LYMPHOMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; EPENDYMOMA; GLIOBLASTOMA; HUMAN; INCIDENCE; MEDULLOBLASTOMA; MENINGIOMA; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PROGNOSIS; REVIEW;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; NEUROSURGICAL PROCEDURES; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PROGNOSIS; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 0347764718     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-003-1645-8     Document Type: Review

References (15)

1. Brandt T, Dichgans J, Diener HC (2003) Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer, München
2. Davis FG, McCarthy BJ, Freels S et al. (1999) The conditional probability of survival of patients with primary malignant brain tumors. Surveillance, epidemiology, and end results (SEER) data. Cancer 85:485-491
3. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114-122
4. Diener HC, Hacke W (2003) Leitlinien der Deutschen Gesellschaft für Neurologie. Thieme, Stuttgart
5. Glioma Meta-analysis Trialists (GMT) Group (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011-1018
6. Herrlinger U, Felsberg J, Küker W et al. (2002) Gliomatosis cerebri. Molecular pathology and clinical course. Ann Neurol 52:390-399
7. Herrlinger U, Schabet M, Brugger W et al. (2002) German cancer society neuro-oncology group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma. Ann Neurol 51:247-252
8. Karim AB, Afra D, Cornu Pet al. (2002) Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52:316-324
9. Kleihues P, Cavenee WK (2000) World Health Organization classification of tumours. Pathology & genetics. Tumours of the nervous system. IARC Press, Lyon
10. Kondziolka D, Lunsford D, McLaughlin MR, Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339:1426-1433
11. Macdonald DR, Cascino TL, Schold SC, Cairncross JG (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277-1280
12. Neuro-Oncology Oncology Group (NOA) of the German Cancer Society (2003) Neuro-Oncology Working Group (NOA)-01 trial of radiotherapy plus adjuvant ACNU/VM26 versus ACNU/Ara-C chemotherapy for malignant glioma. J Clin Oncol 21:3276-3284
13. Pels H, Schmidt-Wolf IGH, Glasmacher A et al. (in press) Primary CNS lymphoma: Results of a pilot/phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol
14. Reifenberger G, Louis DN (2003) Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62:111-126
15. Schlegel U, Weller M, Westphal M (2003) Neuro-Onkologie. Thieme, Stuttgart